Brain injection trial hopes to tame Parkinson's
NCT ID NCT07195825
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times
Summary
This early-stage study tests whether a new gene therapy called BBM-P002 is safe when injected directly into a specific brain area. It involves 18 adults who have had Parkinson's disease for at least 5 years. The main goal is to check for side effects and see how well the treatment is tolerated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200025, China